|
|
|
|
|
|
by refurb
2380 days ago
|
|
|
It’s already being done. The question is, what do you do when you identify a new antibiotic? Who pays for the clinical trials and manufacturing? Academic centers don’t have experience in doing either of those for an FDA approved drug. |
|
|